Legend Biotech Corporation

LEGN·NasdaqGS·Healthcare
Compare
17.80−0.82 (−4.40%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours17.800.00 (0.00%)Oct 12, 4:00 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close18.62
Open18.40
Day range17.6918.49
52-week range16.2437.50
Off day high−3.73%
Off 52-week high−52.53%
Volume2.63M
Avg. volume (3M)2.37M
Market cap3.46B
EPS (TTM)-0.5200
Forward P/E16.95
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.57
Shares outstanding194.49M
Short interest19.92% of float
Earnings dateAug 11, 2026
Analyst target46.19
Profit margin−7.20%

Against its peers

Compare in full ›
LEGN LYEL CGEM GMAB IDYA RCUS
Market cap 3.46B 202.66M 918.80M 22.98B 3.48B 3.06B
P/E (TTM) — — — 29.4 — —
Forward P/E 17.0 -1.3 -5.9 24.5 -9.0 -7.5
Price/book 2.8 0.8 3.0 3.7 2.9 6.7
Dividend yield — — — — — —
1-year change −43.32% −48.25% +98.34% +13.43% +34.89% +46.69%
Today −4.40% −5.05% −3.73% +0.81% −0.14% −0.29%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All LEGN news ›
clinicaltrialvanguard.com·Positive

Legend Biotech: New Myeloma, Lymphoma CAR-T Data at ASH

Topline data: In triple-class–exposed multiple myeloma patients with three prior lines of therapy from CARTITUDE-1, a single infusion of ciltacabtagene autoleucel (CARVYKTI) delivered a median progression-free survival (mPFS) of 50.4…

@gurufocus·Negative

Legend Biotech Corp (LEGN) Director Sanders Corazon (Corsee) D.

Sanders Corazon (Corsee) D., a Director at Legend Biotech Corp LEGN, disclosed a sale of 27,370 shares of the company on 2026-09-29, according to a recent SEC Filing. Following the transaction, the insider owns 52,731 shares of the…

BioBuzz·Positive

Josh Schwartz Joins Legend Biotech as Senior Vice President

Legend Biotech, a global biotechnology company based in New Jersey, has hired Josh Schwartz, MD, MBA as Senior Vice President. Legend develops advanced cell therapies across several technology platforms, including autologous and allogeneic…

Rugby365·

Munster statement: CEO to step down

NEWS: Munster have confirmed that chief executive Ian Flanagan will leave his position at the end of October, bringing his six-year tenure at the Irish province to a close. Flanagan, who was appointed CEO in 2019, informed the Munster…

From articles in the 4Search news index.

In the news

18mentions in 30 days
15with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 18 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.